The Effect of Different Treatment Modalities of Tubal Ectopic Pregnancy on Ovarian Reserve: a Prospective Cohort Study
1 other identifier
observational
90
1 country
1
Brief Summary
Detect the effect of different treatment modalities of tubal ectopic pregnancy on ovarian reserve
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2024
CompletedFirst Posted
Study publicly available on registry
June 24, 2024
CompletedStudy Start
First participant enrolled
July 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2025
CompletedJune 24, 2024
June 1, 2024
1.2 years
June 18, 2024
June 18, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in levels of AMH pre and post treatment
3 months
Study Arms (6)
Conservative management
Medical treatment
Surgical treatment (Open or laparoscopic salpingectomy)
Surgical treatment after failed medical treatment (Open or laparoscopic salpingectomy)
Conservative surgical treatment (salpingotomy, salpingostomy, tubal milking)
Conservative surgical treatment after failed medical treatment
Interventions
Ovarian reserve
Eligibility Criteria
Women's Health Hospital, Department of Obstetrics and Gynecology, Faculty of Medicine, Assiut University
You may qualify if:
- The study will include patients aged 18-44 years with known diagnosis or suspicion of diagnosis of tubal ectopic pregnancy (abnormal doubling rates of their b-HCG levels as well as ultrasonographically identified or unidentified gestational sacs outside the uterus)
- Included patients must have capacity to provide informed consent. Given the potential emergent nature of presentation, women will not be recruited if fully informed consent could be compromised due to a highly distressed emotional state or significant hemorrhage necessitating the need for urgent surgery
You may not qualify if:
- The use of hormonal contraceptives within two months of enrolment
- If other surgery was conducted at the time of salpingectomy.
- If a woman was pregnant at follow up visit for AMH measurement
- History of previous surgeries of fallopian tubes and/or ovaries
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut university
Asyut, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
June 18, 2024
First Posted
June 24, 2024
Study Start
July 10, 2024
Primary Completion
October 1, 2025
Study Completion
October 10, 2025
Last Updated
June 24, 2024
Record last verified: 2024-06